CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,017 | $0.54 | $3K | 37,917 |
| 2024-02-12 | Rodman David Malcom Chief Medical Officer | Option exercise | +6,349 | $1.08 | $7K | 44,266 |
| 2024-02-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,017 | 55,190 | ||
| 2024-02-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −6,349 | 215,851 | ||
| 2024-01-12 | Rodman David Malcom Chief Medical Officer | Option exercise | +6,348 | $1.08 | $7K | 32,900 |
| 2024-01-12 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −6,348 | 222,200 | ||
| 2024-01-11 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,017 | $0.54 | $3K | 26,552 |
| 2024-01-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,017 | 60,207 | ||
| 2023-12-11 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,018 | $0.54 | $3K | 20,069 |
| 2023-12-11 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,018 | 65,224 | ||
| 2023-11-22 | Congleton Jon Chief Executive Officer | Purchase | +4,250 | $5.97 | $25K | 1,049,068 |
| 2023-11-13 | Rodman David Malcom Chief Medical Officer | Option exercise | +5,017 | $0.54 | $3K | 15,051 |
| 2023-11-13 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −5,017 | 70,242 | ||
| 2023-11-03 | Rodman David Malcom Chief Medical Officer | Option exercise | +10,034 | $0.54 | $5K | 10,034 |
| 2023-11-03 | Rodman David Malcom Chief Medical Officer | Option exercise · Stock Option | −10,034 | 75,259 | ||
| 2023-09-13 | Karydas Daphne Director | Grant or award · Stock Option | +44,000 | 44,000 | ||
| 2023-09-13 | SBLENDORIO GLENN Director | Grant or award · Stock Option | +44,000 | 44,000 | ||
| 2023-09-06 | Congleton Jon Chief Executive Officer | Purchase | +2,250 | $12.08 | $27K | 1,044,818 |
| 2023-08-17 | Congleton Jon Chief Executive Officer | Purchase | +2,250 | $12.10 | $27K | 1,042,568 |
| 2023-08-11 | Rodman David Malcom Chief Medical Officer | Option exercise | +80,909 | $0.54 | $44K | 80,909 |
Page 20 of 23 · 446 trades